comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Asco gi - Page 1 : comparemela.com
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
Experts discuss updated findings from key clinical trials in hepatocellular carcinoma presented during the 2024 Gastrointestinal Cancers Symposium.
United-states
Japan
American
Jun-gong
Anthonyb-el-khoueiry
Rachnat-shroff
Michael-morse
European-society-for-medical-oncology-asia-congress
Onclive-peer-exchange
Systemic-therapy
European-society
Medical-oncology-asia-congress
Considerations for Platinum-based Therapy
Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.
Expert-perspectives
Evolving-treatment
Refractory-metastatic-colorectal-cancer
Folfoxiri
Asco-gi
Adverse-event-profiles
Neutropenia
Nausea
Anemia
Hand-foot-skin-reactions
Proteinuria
Dr Dotan on the Use of Geriatric Assessments to Identify Unique Challenges in GI Cancer
Efrat Dotan, MD, discusses the use of geriatric function assessments in elderly patients with gastroesophageal cancer.
Efrat-dotan
Department-of-hematology-oncology
Hematology-oncology-fellowship-training-program
Fox-chase-cancer-center
Medical-oncology
Oncology-fellowship-training-program
Cancers-symposiumshowed
Onclive-tv
Sgi
Geriatric
Asco-gi
Fruzaqla Delays Colorectal Cancer Progression, Prolongs Patient Survival
Findings presented at the 2024 Gastrointestinal Cancers Symposium support Fruzaqla’s potential to provide an improved survival benefit and quality of life for those with previously treated metastatic colorectal cancer.
Sebastian-stintzing
Universitaetsmedizin-berlin
News
Gastric-cancer
Colorectal-cancer
Conference
Asco-gi
Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC
Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.
Newyork-presbyterian-hospital
New-york
United-states
Pashtoon-murtaza-kasi
Weill-cornell-medicine
News
Gastric-cancer
Colorectal-cancer
Asco-gi
Conference
Botensilimab
vimarsana © 2020. All Rights Reserved.